Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Scienture Holdings (SCNX) Capital Expenditures (2020 - 2022)

Scienture Holdings' Capital Expenditures history spans 3 years, with the latest figure at $114943.0 for Q4 2022.

On a quarterly basis, Capital Expenditures changed N/A to $114943.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $450845.0, a N/A change, with the full-year FY2024 number at $12000.0, changed N/A from a year prior.
Capital Expenditures hit $114943.0 in Q4 2022 for Scienture Holdings, up from $55730.0 in the prior quarter.
Over the last five years, Capital Expenditures for SCNX hit a ceiling of $303172.0 in Q2 2022 and a floor of -$23000.0 in Q1 2022.